Log In
Print
BCIQ
Print
Print this Print this
 

Tozadenant (SYN115)

Also known as: SYN-115

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionSelective adenosine A2A receptor (ADORA2A) antagonist
Molecular Target Adenosine A2A receptor (ADORA2A)
Mechanism of ActionAdenosine A2A receptor antagonist
Latest Stage of DevelopmentPhase II
IndicationParkinson's disease (PD)
Partner

Biotie Therapies Corp.; UCB Group
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today